Clinical Trial Update: Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating montelukast for acne vulgaris, focusing on serum ICAM-1 as a biomarker; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: South Valley University | Conditions: Acne Vulgaris | Phase 3 | Status: NOT_YET_RECRUITING